A brain aneurysm (BA) is a condition with potentially fatal consequences that arise from the localized outburst of cerebral arteries.
According to NIH, Brain Aneurysms are 3.2% common worldwide, with a mean age of 50 and a gender ratio of 1:1 overall. After the age of 50, this ratio drastically shifts, with a growing female predominance that approaches a 2:1 ratio. This is believed to be caused by a decrease in circulating estrogen, which lowers the amount of collagen in vascular tissue. Ruptures that result in subarachnoid hemorrhage (SAH) happen roughly once every 100,000 people. Certain populations—like the Finnish and Japanese populations—have higher rates of this. This, however, is not because aneurysms are more common in these populations. Aneurysmal SAH is thought to account for 0.4 to 0.6% of all-cause deaths overall, with a 20% mortality rate and an additional 30 to 40% morbidity in patients with known rupture.
As per the report of the Brain Aneurysm Organization, 1 in 50 persons, or 6.7 million people, in the US are thought to have an unruptured brain aneurysm. About 8 to 10 ruptures occur for every 100,000 people annually. Every year in the US, aneurysm ruptures affect about 30,000 people. Every 18 minutes, a brain aneurysm bursts. Brain aneurysms cause approximately 500,000 deaths worldwide each year, with half of the victims being under 50.
A Brain Aneurysm (BA) also called Cerebral Aneurysm or Cranial Aneurysm is a weak spot in a brain blood vessel that bulges. The cerebral aneurysm eventually burst as a result of this artery wall weakness. Brain bleeding, or subarachnoid hemorrhage, is a dangerous condition that results from a ruptured aneurysm. It is thought that aneurysms develop gradually as a result of blood flow across a weak point. Unnoticed small brain aneurysms are a common condition in many people.
Certain brain aneurysms, especially small ones, don't bleed or cause any other issues. This type of aneurysm is typically found during imaging examinations for different illnesses. Although they develop anywhere in the brain, most cerebral aneurysms originate in the main arteries that run along the base of the skull. Every cerebral aneurysm carries the risk of burst, which results in bleeding into the brain or surrounding tissues.
There are three types of Brain Aneurysm (BA). A Saccular Aneurysm, a spherical sac filled with blood that is connected to either the main artery or one of its branches is called a saccular aneurysm. This is the most common type of cerebral aneurysm, also referred to as a berry aneurysm (because it looks like a berry hanging from a vine). A Fusiform Aneurysm, is an artery that has a fusiform aneurysm swell or protrudes on all sides and a Mycotic Aneurysm is an infection that occasionally affects the brain's arteries results in a mycotic aneurysm. When an artery wall becomes weaker due to infection, a bulging aneurysm forms. Aneurysms are also classified based on size as small, large, and giant with sizes 11mm, 11to15 mm, and 25mm in diameter respectively.
The following conditions cause or increase the risk of BA: vascular Ehlers-Danlos syndrome, autosomal dominant polycystic kidney disease, Marfan syndrome, fibromuscular dysplasia, arteriovenous malformation, alcohol use, and smoking. A rupture is most frequently caused by high blood pressure. Blood presses more forcefully against blood vessel walls when blood pressure is higher. Conditions that raise blood pressure and cause a ruptured brain aneurysm.
Symptoms of Brain Aneurysm are based on whether the cell is ruptured or not or it is leaked.
Symptoms of Ruptured Brain Aneurysm include thunderclap headache (severe, abrupt onset), vomiting and nausea, tense neck, double or blurry vision, Light sensitivity (photophobia), Agencies, dilated pupil and drooping eyelid, discomfort behind and above the eyes, Perplexity, feebleness and/or numbness, consciousness is lost.
Most Unruptured Brain Aneurysms (intact) don't show any symptoms. If the bulge in the artery gets big enough, it may press on the brain tissue or surrounding nerves, resulting in headaches, altered vision, enlarged (dilated) pupils, tingling or numbness in the face or head, and Sensations of pain behind and above the eyes.
In Leaking Brain Aneurysm, A tiny amount of blood occasionally leaks into the brain from an aneurysm; this is known as a sentinel bleed. Days or weeks before a major rupture, a small leak in an aneurysm causes sentinel or warning headaches. However, very few people experience a sentinel headache before rupture.
Diagnosing Brain Aneurysm
The majority of cerebral aneurysms remain undetected until they burst or become apparent during imaging tests for other conditions.
To identify the best course of action for treating brain aneurysms, several tests are available. These include:
Imaging Test
Blood Test
Diagnostic Market Players |
Diagnostic Products |
General Electric Company (GE Healthcare) |
Revolution™ CT |
TECHNOMAC |
Optima™ CT |
Siemens Healthineers |
Discovery™ CT |
Med Imaging Solutions |
SIGNA™ MRI |
Canon Medical Systems Corporation |
SIGNA™ Pioneer |
Gastro diagnostic.Ltd |
SIGNA™ Architect |
Radiance Imaging system |
Discovery™ PET/CT |
Fujifilm Holdings Corporation (FUJIFILM Medical Systems) |
VUE Point™ FX |
|
Discovery™ MI |
Reducing or stopping the blood flow into the aneurysm is the primary objective of treatment for brain aneurysms. Emergency surgery is needed for a brain aneurysm that is leaking or has burst. Depending on the situation, the patient might not require treatment for an unruptured aneurysm.
Surgery, endovascular treatments, or additional medicinal therapies are frequently recommended to manage symptoms and prevent impairment from Brain Aneurysms.
Surgery
For the treatment of cerebral aneurysms, a few surgical options are available. There is a chance that these procedures will cause damage to other blood vessels, that the aneurysm will recur and cause bleeding again, and that a stroke may occur.
Endovascular Treatment
Medicines
Medicinal treatments in Brain Aneurysms aim to control symptoms and diminish complications. These include:
Rehabilitation Counselling- After a subarachnoid hemorrhage, people frequently require occupational, speech, and physical therapy to regain function and learn how to live with a permanent disability.
Treatment Market Players |
Treatment Products |
Medtronic |
Yasargil® |
Integra LifeSciences |
Embold Fibered Coil |
InfraScan |
IDC™ |
MicroPort Scientific Corporation |
FRED® |
Renolit |
Surpass Evolve™ |
Spiegelberg |
WEB™ |
Johnson & Johnson. |
Cathflo® |
Stryker |
Activase® |
B. Braun Melsungen AG |
Cleviprex® |
Terumo Corporation |
Alka-seltzer® |
Microvention Inc. |
Nimodipine® |
The increasing emphasis on comparative effectiveness research by the government emphasizes the importance of clinical trials in the practice of evidence-based medicine and health care reform. Clinical data helps the market players to accurately compare medical therapy and achieve one of the primary goals of health care reform.
The study titles of the currently active clinical trials, as well as the phases in which they are being conducted, are included in the table below.
PHASE 1 (Human Pharmacology) |
PHASE 2 (Therapeutic Exploratory Trail) |
PHASE 3 (Therapeutic Confirmatory Trial) |
PHASE 4 (Post Marketing Surveillance) |
|
Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms |
Evaluating Oral Peri-operative Acetylsalicylic Acid in Subjects Undergoing Endovascular Coiling-only of Unruptured Brain Aneurysms |
Evaluate the Use of Glibenclamide on Acute aSAH |
|
Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia |
|
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling |
|
|
|
Reduction of Microembolism After the Intervention Surgery of Intracranial Aneurysms by Administration of Tirofiban |
Disease Landscape Insights (DLI) assists manufacturers in developing and implementing viable remedies to interrupt and manage amyotrophic lateral sclerosis outbreaks. Furthermore, there is an increasing need for diagnostic tools, clinical evaluations, and ALS gene therapy as a result of greater awareness and estimated epidemics.
Disease Landscape Insights offers essential knowledge and expertise to major stakeholders involved in the manufacture of therapeutic goods. DiseaseLandscape Insights' support makes it easier for market participants to organize and carry out clinical trials for innovative medicines and pharmaceuticals, patient recruiting tactics, and regulatory compliance. By understanding disease patterns, treatment needs, and technological advancements, companies tailor their products and services to meet evolving demands and foster business expansion and success.
How we can help?